These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26468184)

  • 1. New Perspectives for the Rescue of Cognitive Disability in Down Syndrome.
    Bartesaghi R; Haydar TF; Delabar JM; Dierssen M; Martínez-Cué C; Bianchi DW
    J Neurosci; 2015 Oct; 35(41):13843-52. PubMed ID: 26468184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Hamlett ED; Boger HA; Ledreux A; Kelley CM; Mufson EJ; Falangola MF; Guilfoyle DN; Nixon RA; Patterson D; Duval N; Granholm AC
    Curr Alzheimer Res; 2016; 13(1):35-52. PubMed ID: 26391050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cognitive phenotype of Down syndrome: insights from intracellular network analysis.
    Ma'ayan A; Gardiner K; Iyengar R
    NeuroRx; 2006 Jul; 3(3):396-406. PubMed ID: 16815222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.
    Fulton SL; Wenderski W; Lepack AE; Eagle AL; Fanutza T; Bastle RM; Ramakrishnan A; Hays EC; Neal A; Bendl J; Farrelly LA; Al-Kachak A; Lyu Y; Cetin B; Chan JC; Tran TN; Neve RL; Roper RJ; Brennand KJ; Roussos P; Schimenti JC; Friedman AK; Shen L; Blitzer RD; Robison AJ; Crabtree GR; Maze I
    Nat Commun; 2022 Oct; 13(1):6384. PubMed ID: 36289231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach.
    Abukhaled Y; Hatab K; Awadhalla M; Hamdan H
    J Neurol; 2024 Jan; 271(1):87-104. PubMed ID: 37561187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.
    Waugh KA; Minter R; Baxter J; Chi C; Galbraith MD; Tuttle KD; Eduthan NP; Kinning KT; Andrysik Z; Araya P; Dougherty H; Dunn LN; Ludwig M; Schade KA; Tracy D; Smith KP; Granrath RE; Busquet N; Khanal S; Anderson RD; Cox LL; Estrada BE; Rachubinski AL; Lyford HR; Britton EC; Fantauzzo KA; Orlicky DJ; Matsuda JL; Song K; Cox TC; Sullivan KD; Espinosa JM
    Nat Genet; 2023 Jun; 55(6):1034-1047. PubMed ID: 37277650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down syndrome.
    Antonarakis SE; Skotko BG; Rafii MS; Strydom A; Pape SE; Bianchi DW; Sherman SL; Reeves RH
    Nat Rev Dis Primers; 2020 Feb; 6(1):9. PubMed ID: 32029743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of pharmacotherapies for cognition in Down syndrome.
    Gardiner KJ
    Trends Pharmacol Sci; 2010 Feb; 31(2):66-73. PubMed ID: 19963286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down Syndrome: Neuropsychological Phenotype across the Lifespan.
    Pulsifer M
    Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of therapies for Down syndrome: the sooner, the better.
    Stagni F; Giacomini A; Guidi S; Ciani E; Bartesaghi R
    Front Behav Neurosci; 2015; 9():265. PubMed ID: 26500515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Dyrk1A, a Down Syndrome Candidate, Decreases Excitability and Impairs Gamma Oscillations in the Prefrontal Cortex.
    Ruiz-Mejias M; Martinez de Lagran M; Mattia M; Castano-Prat P; Perez-Mendez L; Ciria-Suarez L; Gener T; Sancristobal B; García-Ojalvo J; Gruart A; Delgado-García JM; Sanchez-Vives MV; Dierssen M
    J Neurosci; 2016 Mar; 36(13):3648-59. PubMed ID: 27030752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model.
    Valenti D; de Bari L; de Rasmo D; Signorile A; Henrion-Caude A; Contestabile A; Vacca RA
    Biochim Biophys Acta; 2016 Jun; 1862(6):1093-104. PubMed ID: 26964795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of understanding individual differences in Down syndrome.
    Karmiloff-Smith A; Al-Janabi T; D'Souza H; Groet J; Massand E; Mok K; Startin C; Fisher E; Hardy J; Nizetic D; Tybulewicz V; Strydom A
    F1000Res; 2016; 5():. PubMed ID: 27019699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.
    Salehi A; Ashford JW; Mufson EJ
    Curr Alzheimer Res; 2016; 13(1):2-6. PubMed ID: 26487155
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions.
    Fonseca LM; Navatta AC; Bottino CM; Miotto EC
    Dement Geriatr Cogn Dis Extra; 2015; 5(3):330-40. PubMed ID: 26483832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models.
    Souchet B; Guedj F; Penke-Verdier Z; Daubigney F; Duchon A; Herault Y; Bizot JC; Janel N; Créau N; Delatour B; Delabar JM
    Front Behav Neurosci; 2015; 9():267. PubMed ID: 26539088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide miR-155 and miR-802 target gene identification in the hippocampus of Ts65Dn Down syndrome mouse model by miRNA sponges.
    Bofill-De Ros X; Santos M; Vila-Casadesús M; Villanueva E; Andreu N; Dierssen M; Fillat C
    BMC Genomics; 2015 Nov; 16():907. PubMed ID: 26546125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling of the postnatal brain of the Ts1Cje mouse model of Down syndrome.
    Tan KL; Ling KH; Hewitt CA; Cheah PS; Simpson K; Gordon L; Pritchard MA; Smyth GK; Thomas T; Scott HS
    Genom Data; 2014 Dec; 2():314-7. PubMed ID: 26484118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrioventricular septal defect: From embryonic development to long-term follow-up.
    Calkoen EE; Hazekamp MG; Blom NA; Elders BB; Gittenberger-de Groot AC; Haak MC; Bartelings MM; Roest AA; Jongbloed MR
    Int J Cardiol; 2016 Jan; 202():784-95. PubMed ID: 26476030
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.